Navigation Links
Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen™
Date:4/2/2012

WOOD DALE, Ill., April 2, 2012 /PRNewswire/ -- Smith Medical Partners, the specialty pharmaceutical subsidiary of H. D. Smith, today announced an exclusive logistics and cold chain services agreement with Cardium Therapeutics (NYSE Amex: CXM), a health sciences and regenerative medicine company, to support its recently launched wound care product, Excellagen™.  Excellagen is a professional-use, syringe-based wound care product used in the management of diabetic foot ulcers, pressure ulcers and other dermal wounds. 

"The secure and efficient distribution of specialty pharmaceutical products is a critical and growing need for the U.S. healthcare system – particularly because so many innovative medicines require specialized handling and dispensing," stated Dave DuRoss, president, Smith Medical Partners.  "Combining our logistics expertise with the manufacturing capabilities of leaders such as Cardium enables us to support the launch and distribution of specialty products that impact patient care, like Excellagen."

The U.S. Centers for Disease Control and Prevention (CDC) estimates that approximately 26 million people in the United States had diabetes in 2010(1). Diabetic foot ulcers, a major complication of diabetes, occur in 15 percent of diabetes patients and precede 84 percent of all lower leg amputations(2).  H. D. Smith and Smith Medical Partners are well positioned to provide distribution and specialized services along the entire specialty pharmaceutical supply chain – from the manufacturer to the patient. 

"As a growing segment of H. D. Smith's business, Smith Medical Partners seeks to be a leader in the specialty marketplace, offering a full-service model of support for manufacturers and customers – from bench to bedside," said Dale Smith, H. D. Smith Chief Executive Officer.  "The partnership wit
'/>"/>

SOURCE Smith Medical Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. GlaxoSmithKline Accelerates Review of Exelixis XL880
3. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
4. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
5. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
6. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
7. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
8. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
9. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
10. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
11. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  Today, Levi ... new extension to its PageCenterX ® content ... is designed to provide downtime reporting capabilities to ... LRS is releasing the product for general availability, ... EMR applications experience outages for a variety of ...
(Date:7/31/2014)... 2014 Orexigen® Therapeutics, Inc. (Nasdaq: ... quarter 2014, on Thursday, August 7, 2014 before markets ... webcast and conference call at 8:00 a.m. Eastern time ... host the call and webcast to discuss financial results ... accessed by calling (800) 708-4540 (domestic) or (847) 619-6397 ...
(Date:7/31/2014)... , July 31 2014  Northsight Capital, Inc. ... has been named Chairman and CEO of the company. ... management, legal matters, business development and investment banking. Mr. ... securities industry.  Before his career on Wall Street, Mr. ... of the U.S, Securities and Exchange Commission in ...
Breaking Medicine Technology:LRS Announces Downtime Reporting Solution for Healthcare 2Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Northsight Capital, Inc. Names Wall Street Veteran John Bluher, Former EVP And General Counsel Of Knight Trading Group, Chairman And CEO. 2
... PALO ALTO, Calif., May 3, 2011 Jazz Pharmaceuticals, Inc. (Nasdaq: ... first quarter of 2011. Total revenues for ... to $35.2 million for the first quarter of 2010.  Total ... GAAP net income for the first quarter of 2011 ...
... 3, 2011 Coast Dental Services, Inc., announced today ... the assets of Dental Technology, Inc. (DTI), doing business ... licensed  health care service plan. DTI and its subsidiaries ... Texas, employing 1,200 staff members, including 130 dentists.  The ...
Cached Medicine Technology:Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 2Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 3Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 4Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 5Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 6Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 7Coast Dental to Acquire the Assets of SmileCare 2
(Date:7/31/2014)... news release is available in German . ... from baby blues after giving birth. Some even develop ... oxidase A, an enzyme responsible for the breakdown of ... in this condition. In comparison to healthy women, women ... the enzyme in their brains. This was discovered by ...
(Date:7/31/2014)... University medical and nursing school researchers hope to ... who participate in clinical trials, a critical step ... , For various reasonsincluding a lack of awareness ... cancer patients take part in trials of experimental ... patients who are eligible still don,t enroll, according ...
(Date:7/31/2014)... Calif. and Las Vegas, Nevada (PRWEB) July 31, 2014 ... with LaunchKey to provide next generation authentication services to ... and secure way to utilize hardware protected multi-factor authentication ... problem in the Internet's reliance on password-based authentication. It ... and global data breaches taking place around the globe. ...
(Date:7/31/2014)... FRANCISCO & ATLANTA (PRWEB) July 31, 2014 ... executive networking and relationship-marketing firm, honored finalists and ... ISE® West Executive Forum and Awards Gala at ... , Max Solonski, director of information security for ... Security Executive® of the Year Award winner for ...
(Date:7/31/2014)... HealthDay Reporter WEDNESDAY, July ... is growing increasingly resistant to the drugs commonly used to ... drugs are in development, and at least one in early ... "Although there has been considerable progress in malaria control ... from won, and there is still much more to do," ...
Breaking Medicine News(10 mins):Health News:Monoamine oxidase A: Biomarker for postpartum depression 2Health News:Monoamine oxidase A: Biomarker for postpartum depression 3Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 2Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 3Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 3Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 2Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 3Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 4Health News:Malaria Growing Resistant to Drugs Used to Fight It 2Health News:Malaria Growing Resistant to Drugs Used to Fight It 3
... Each year about 400,000 Americans undergo balloon angioplasty to clear ... Now, a cancer drug may change the outcome of the ... doing everything he can to avoid a second open-heart surgery. ... ,But earlier this year, Bailey had the same ...
... late at night, when hunger strikes may seem a familiar ... people do // not eat enough throughout the day. People ... tend to crave carbs and sweets . ,Studies show ... and angry. When these same people resume normal eating habits, ...
... Based on the results of a recent study researchers ... value of stretching before exercising.// Specialists say stretching does ... research shows static stretching makes muscles weaker for 10 ... of injury. They say some likely causes of injuries ...
... to an increased risk of breast cancer say researchers based ... who experienced a short, but severe decrease in food intake ... breast cancer than women not affected by the famine. ... Dutch famine participated in the Dutch breast cancer screening program ...
... blindness in the United States. It affects the blood vessels ... at the back of the eye. Retinopathy occurs in most ... with aggressive control of blood glucose and blood pressure. New ... suffer from diabetic retinopathy, and that number is expected to ...
... Neuro scientists say new findings in animals suggest a ... other nervous system injuries . ,"Our approach is ... themselves,// called the stress protein response," say specialists . ... prevent or minimize the "secondary" cell death that occurs ...
Cached Medicine News:Health News:New Findings Could Reduce The Extent Of Spinal Cord Injuries 2
... supply is the latest edition ... offering. It sets new standards ... This product has unique features ... as microAmp detector, display and ...
... as a constant voltage power supply, the 105 ... and hilo range switch control the output, which ... 250 volts. One, two-position switch toggles the bright ... current. The 105 is equipped with an over ...
... power supply is capable of producing up to ... product operates in constant voltage or constant current ... crosses over from one mode of operation to ... A dual function, auto ranging 24-hour ...
... designed for horizontal and vertical gel electrophoresis ... accomplished. In this power supply model, output ... or constant voltage. Four sets of output ... simultaneously. This power supply's light, compact and ...
Medicine Products: